logo
  

Hubei Henglong Automotive Systems Buys 40% Stake In Swedish Automotive Tech Co. Sentient

China Automotive Systems, Inc. (CAAS) Wednesday announced that Hubei Henglong Automotive Systems Group Co. Ltd., a unit of the company, has bought 40% stake in Sentient AB, a Swedish automotive technology company.

Jingzhou WiseDawn Electric Car Co., Ltd. will sell its Sentient shares to Henglong for about 20 million euros, to be paid in cash in three tranches.

Two directors of CAAS, Hanlin Chen and Qizhou Wu, are the majority and minority owners of WiseDawn.

Founded in 2009, Sentient provides software development and hardware design for advanced steering functions, vehicle motion control and autonomous driving.

"With the rise of artificial intelligence and electrification taking the automotive sector by storm, we are committed to elevating our steering technologies for the advancement and empowerment of autonomous driving in the foreseeable future. By joining our combined resources, technology and customer bases in China, Europe, the US and South America, we look forward to capturing more market opportunities and expanding our market share globally," Qizhou Wu, chief executive officer of CAAS, commented.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The 737 MAX 10, Boeing Co.'s largest 737 Max model, is taking its maiden flight today, reports said citing people familiar with the matter. The flight after months of testing and certification will be around 10 a.m. local time from the Seattle area. The schedule could change depending on weather or other factors. Meanwhile, the jetliner is expected to enter commercial service in 2023. Medical devices supplier Smiths Medical, affiliated to Smiths Group plc, is recalling certain Jelco Hypodermic Needle-Pro Fixed Needle insulin syringes with skewed graduation markings, the U.S. Food and Drug Administration said. The recall was initiated after the company became aware of specific models and lots of Jelco insulin syringes that may exhibit skewed odd number line graduation markings. Saliva-based COVID-19 testing is rolled out as a pilot for public schools in New York City. The new two-month pilot program is being implemented in about 50 New York City public schools and utilizes Fluidigm Technology to offer RT-PCR COVID-19 testing. New York City public schools have instituted mandatory random weekly testing in all reopened school buildings to ensure safer in-person learning.
Follow RTT